Abstract
Efforts to improve the survival of patients with metastatic malanoma have led to 67 prospective randomized clinical trials investigating the use of agents three main areas of therapy: systematic chemotherapy-based regimens, immunotherapy, and vaccine therapy.
Original language | English |
---|---|
Pages (from-to) | 23-52 |
Number of pages | 30 |
Journal | Surgical Oncology Clinics of North America |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - 2002 |
Externally published | Yes |